Online inquiry

IVTScrip™ mRNA-Human ADAT2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8916MR)

This product GTTS-WK8916MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAT2 protein. This product can be used in Regulatory T (Treg) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001286259.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 134637
UniProt ID Q7Z6V5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAT2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8916MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27896MR IVTScrip™ mRNA-Human ATP5C1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ATP5C1
GTTS-WK13562MR IVTScrip™ mRNA-Human ABHD13, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ABHD13
GTTS-WK12483MR IVTScrip™ mRNA-Human ACYP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACYP2
GTTS-WK12362MR IVTScrip™ mRNA-Human ABHD13, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABHD13
GTTS-WK13622MR IVTScrip™ mRNA-Human ACE2, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ACE2
GTTS-WK17812MR IVTScrip™ mRNA-Human ALG12, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALG12
GTTS-WK26613MR IVTScrip™ mRNA-Human ASH2L, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ASH2L
GTTS-WK23920MR IVTScrip™ mRNA-Human ASNS, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASNS
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →